Description
Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) designed to boost the body’s natural production of growth hormone. It is primarily prescribed to reduce excess visceral fat in patients with HIV-associated lipodystrophy, helping improve abdominal fat distribution and metabolic health.
By stimulating the pituitary gland, Tesamorelin encourages the release of growth hormone, which plays a key role in regulating fat metabolism, muscle growth, and overall body composition. Clinical studies have shown Tesamorelin to be effective in reducing visceral adipose tissue without significant adverse effects on glucose metabolism.
This peptide is administered via subcutaneous injection and should be used under medical supervision. Tesamorelin is typically part of a comprehensive management plan including diet, exercise, and other therapies to optimize patient outcomes.
Key Benefits:
- Targets reduction of visceral abdominal fat
- Enhances natural growth hormone secretion
- Supports improved body composition
- Used primarily in HIV-associated lipodystrophy treatment
Usage:
Administered by subcutaneous injection as per prescribed dosage. Consult healthcare provider for detailed instructions.
Reviews
There are no reviews yet.